Our mission is to triple the pancreatic cancer survival rate by 2030 and dramatically improve the quality of life for those impacted by the disease.

PanKind, The Australian Pancreatic Cancer Foundation, is exclusively dedicated to improving outcomes for Australians impacted by pancreatic cancer.

We are achieving results through a strategic investment in groundbreaking medical research and critically, PanKind is often the first to provide funding for these projects. We are the lead funder, identifying the potential for patients and providing the initial investment to enable projects to grow bigger and have a greater impact.

Early-stage pancreatic cancer rarely causes signs or symptoms, which can make it difficult to diagnose, that is why we are working towards a breakthrough in early detection. We also support patients and carers through information and resources, and advocating for better patient outcomes.

We know from work in other cancers that medical research is the single most important factor impacting patient survival. Due to extensive funding, more high profile cancers now have 5-year survival rates above 90%. It’s time to make the same improvements for pancreatic cancer.

We invite you to join us on the journey to improve survival rates and the quality of life for the thousands of Australians affected by this disease every year.